Predicting the function of transplanted kidney in long-term care processes: Application of a hybrid model.


Journal

Journal of biomedical informatics
ISSN: 1532-0480
Titre abrégé: J Biomed Inform
Pays: United States
ID NLM: 100970413

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 13 2 2019
medline: 20 6 2020
entrez: 13 2 2019
Statut: ppublish

Résumé

A tool that can predict the estimated glomerular filtration rate (eGFR) in routine daily care can help clinicians to make better decisions for kidney transplant patients and to improve transplantation outcome. In this paper, we proposed a hybrid prediction model for predicting a future value for eGFR during long-term care processes. Longitudinal, historical data of 942 transplant patients who received a kidney between 2001 and 2016 at Urmia kidney transplant center was used to develop a hybrid model. The model was based on three primary models: multi-layer perceptron (MLP), linear regression (LR), and a model that predicted a smoothed value of eGFR. The hybrid model used at-hand, longitudinal data of physical examinations and laboratory test values available at each visit. Two different datasets, a generalized dataset (GData) and a personalized dataset (PData), were created. Then, in both datasets, two data subsets of development and validation were created. For prediction, all records related to the fourth to tenth previous visits of patients in time order from the target date, i.e., window size (WS) = 4-10, were used. The performance of the models was evaluated using Mean Square Error (MSE) and Mean Absolute Error (MAE). The differences between the models were evaluated with the F-test and the Akaike Information Criterion (AIC). The datasets contained 35,066 records, totally. The GData contained 26,210 and 8856 records and the PData had 24,079 and 9103 records in the development and validation datasets, respectively. In the hybrid model, the MSE and MAE were 153 and 8.9 in the GData, and 113 and 7.5 in the PData, respectively. The model performance improved using a wider WS of historical records (from 4 to 10). When the WS of ten was used the MSE and MAE declined to 141 and 8.5 in the GData and to 91 and 6.9 in the PData, respectively. In both datasets, the F-test showed that the hybrid model was significantly different from other models. The AIC showed that the hybrid model had a better performance than that of others. The hybrid model can predict a reliable future value for eGFR. Our results showed that longitudinal covariates help the models to produce better results. Smoothing eGFR values and using a personalized dataset to develop the models also improved the models' performances. They can be considered as a step forward towards personalized medicine.

Sections du résumé

BACKGROUND
A tool that can predict the estimated glomerular filtration rate (eGFR) in routine daily care can help clinicians to make better decisions for kidney transplant patients and to improve transplantation outcome. In this paper, we proposed a hybrid prediction model for predicting a future value for eGFR during long-term care processes.
METHODS
Longitudinal, historical data of 942 transplant patients who received a kidney between 2001 and 2016 at Urmia kidney transplant center was used to develop a hybrid model. The model was based on three primary models: multi-layer perceptron (MLP), linear regression (LR), and a model that predicted a smoothed value of eGFR. The hybrid model used at-hand, longitudinal data of physical examinations and laboratory test values available at each visit. Two different datasets, a generalized dataset (GData) and a personalized dataset (PData), were created. Then, in both datasets, two data subsets of development and validation were created. For prediction, all records related to the fourth to tenth previous visits of patients in time order from the target date, i.e., window size (WS) = 4-10, were used. The performance of the models was evaluated using Mean Square Error (MSE) and Mean Absolute Error (MAE). The differences between the models were evaluated with the F-test and the Akaike Information Criterion (AIC).
RESULTS
The datasets contained 35,066 records, totally. The GData contained 26,210 and 8856 records and the PData had 24,079 and 9103 records in the development and validation datasets, respectively. In the hybrid model, the MSE and MAE were 153 and 8.9 in the GData, and 113 and 7.5 in the PData, respectively. The model performance improved using a wider WS of historical records (from 4 to 10). When the WS of ten was used the MSE and MAE declined to 141 and 8.5 in the GData and to 91 and 6.9 in the PData, respectively. In both datasets, the F-test showed that the hybrid model was significantly different from other models. The AIC showed that the hybrid model had a better performance than that of others.
CONCLUSIONS
The hybrid model can predict a reliable future value for eGFR. Our results showed that longitudinal covariates help the models to produce better results. Smoothing eGFR values and using a personalized dataset to develop the models also improved the models' performances. They can be considered as a step forward towards personalized medicine.

Identifiants

pubmed: 30753950
pii: S1532-0464(19)30034-6
doi: 10.1016/j.jbi.2019.103116
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103116

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Parviz Rashidi Khazaee (P)

Electrical and Computer Engineering Department, Urmia University, Urmia, Iran; Urmia University of Technology, Urmia, Iran.

Jamshid Bagherzadeh M (J)

Electrical and Computer Engineering Department, Urmia University, Urmia, Iran.

Zahra Niazkhani (Z)

Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran.

Habibollah Pirnejad (H)

Patient Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran; Erasmus School of Health Policy & Management (ESHPM), Erasmus University Rotterdam, Rotterdam, the Netherlands. Electronic address: pirnejad.h@umsu.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH